| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |